Press release
Chronic Obstructive Pulmonary Disease (COPD) Drug Market 2020: Global Industry Exhibits Huge Growth by Top Key Players Novartis AG, Chiesi Farmaceutici S.p.A , Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd
Global Chronic Obstructive Pulmonary Disease (COPD) Drug Market
Chronic Obstructive Pulmonary Disease (COPD) Drug Market is rising gradually to an estimated value of USD 69.29 billion by 2026 registering a steady CAGR of 4.3% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients, growing prevalence of chronic obstructive pulmonary disease (COPD) associated diseases and rising patient population and increase in availability of novel combination therapy drugs. A few of the major competitors currently working in the chronic obstructive pulmonary disease (COPD) drug market are AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, Chiesi Farmaceutici S.p.A , Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Orion Corporation, Merck & Co., Inc, Abbott, F. Hoffmann-La Roche Ltd, Vectura Group plc, Pfizer Inc, Alkermes, Mylan N.V, Almirall, S.A, Genentech, Inc, Biogen, Vectura Group plc and few among others.
Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-chronic-obstructive-pulmonary-disease-copd-drug-market&pm
Market Definition: Global Chronic Obstructive Pulmonary Disease (COPD) Drug Market
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease which is characterized by increasing breathlessness, wheezing, and tightness in the chest. The patient of chronic obstructive pulmonary disease (COPD) experiences chronic chough, shortness of breath, fatigue, frequent flu and weight-loss. Other symptoms include emphysema, chronic bronchitis, refractory asthma and some forms of bronchiectasis.
The Global Burden of Disease Study reports a prevalence of 251.00 million cases of chronic obstructive pulmonary disease (COPD) globally in 2016. Globally, it is estimated that 3.17 million deaths were caused by the disease in 2015 (that is, 5% of all deaths globally in that year)
Market Drivers
Growing prevalence of chronic obstructive pulmonary disease (COPD) associated diseases
Rising patient population and increase in availability of novel combination therapy drugs
Increasing awareness regarding chronic obstructive pulmonary disease (COPD)
High smoking prevalence
Growing medical spending, increasing global healthcare expenditure and technological advancements in pharmaceuticals research
Market Restraints
Effective treatment is either unavailable or unaffordable
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth of the market
Lack of awareness among the patient and physician about chronic obstructive pulmonary disease (COPD) treatment
Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-chronic-obstructive-pulmonary-disease-copd-drug-market&pm
Key Developments in the Market:
In April 2019, Circassia and AstraZeneca received collaborative FDA approval for Duaklir which is a fixed-dose combination of the long-acting muscarinic antagonist (LAMA) aclidinium bromide and long-acting beta-agonist (LABA) formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease (COPD), administered twice-daily via the AstraZeneca's breath-actuated inhaler Pressair
In February 2019, Mylan N.V received FDA approval for Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP) which is first generic version of Advair Diskus by GlaxoSmithKline Plc. This drug is used for the treatment of asthma or other chronic obstructive pulmonary disease (COPD). As it is a first substitutable generic of ADVAIR DISKUS it increases affordability to all healthcare system
For More Insights Get Detailed TOC @https://www.databridgemarketresearch.com/toc?dbmr=global-chronic-obstructive-pulmonary-disease-copd-drug-market&pm
Segmentation: Global Chronic Obstructive Pulmonary Disease (COPD) Drug Market
By Type
Chronic bronchitis
Pulmonary emphysema
Asthma
By Mechanism Type
Bronchodilators
Selective ?2-adrenergic agonists (short- and long-acting)
Theophylline
Anticholinergics
Glucocorticoids
Anti-muscarinic drugs
By Drug Type
Aclidinium
Arformoterol
Formoterol
Glycopyrrolate
Indacaterol
albuterol
Levalbuterol
Prednisolone
Fluticasone
By Therapy
Oxygen therapy
Pulmonary Rehabilitation Program
By Route of Administration
Oral
Inhaled
Intravenous
Others
By Device Type
Inhalers
Pressurized metered-dose inhalers (MDIS)
Dry-powder inhalers (DPIS)
Nebulizers
Soft mist inhalers
Others
By End User
Hospitals
Homecare
Specialty Clinics
Others
Reasons to Purchase this Report
Current and future of global chronic obstructive pulmonary disease drug market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Obstructive Pulmonary Disease (COPD) Drug Market 2020: Global Industry Exhibits Huge Growth by Top Key Players Novartis AG, Chiesi Farmaceutici S.p.A , Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd here
News-ID: 1964635 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for COPD
Copd Drugs Market Size Analysis by Application, Type, and Region: Forecast to Co …
USA, New Jersey- According to Market Research Intellect, the global Copd Drugs market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
Because respiratory problems are becoming more common worldwide, especially among smokers and older populations, the market for COPD medications is expanding steadily. The need…
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market 2024-2030 Growth: …
Growth: Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights :
For stakeholders, an optimistic view is shown by the thorough study of the worldwide "Chronic Obstructive Pulmonary Disease (COPD) Treatment market". The research provides specifics on the market's historical and present conditions as well as projected trends and size. Decision-makers may navigate the competitive environment and investment possibilities in the Chronic Obstructive Pulmonary Disease (COPD) Treatment market with the use of…
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market - Breathing Sol …
Newark, New Castle, USA - new report, titled Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Obstructive Pulmonary Disease (COPD) Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Obstructive Pulmonary Disease…
Asthma & COPD Drugs Market - Breathe Freely, Live Fully: Empowering Respiratory …
Newark, New Castle, USA - new report, titled Asthma & COPD Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Asthma & COPD Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Asthma & COPD Drugs market. The report offers…
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing…
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's.
It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be…
